<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02516215</url>
  </required_header>
  <id_info>
    <org_study_id>201505008RINA</org_study_id>
    <nct_id>NCT02516215</nct_id>
  </id_info>
  <brief_title>Sublingual Microcirculation Data of Patients With Systemic Diseases</brief_title>
  <official_title>Population Research of Sublingual Microcirculation Data of Patients With Systemic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational clinical study, patients with systemic diseases will be enrolled&#xD;
      according to the inclusion and exclusion criteria. 360 patients will received the examination&#xD;
      of sublingual microcirculation by using sidestream dark filed video microscope. The&#xD;
      microcirculation data includes total small vessel density, perfused small vessel density,&#xD;
      microvascular flow index, and heterogeneity index. The patients will be divided into right&#xD;
      groups according to their systemic diseases as follows: group 1 hypertension (60 patients),&#xD;
      group 2 diabetes mellitus (60), group 3 hypertension and diabetes mellitus (60), group 4 end&#xD;
      stage renal disease with hemodialysis (60), group 5 peripheral arterial occlusive disease&#xD;
      (30), group 6 coronary artery disease (30), group 7 liver cirrhosis (30), and group 8 anemia&#xD;
      (30).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total small vessel density of sublingual small vessels</measure>
    <time_frame>Once at enrollment</time_frame>
    <description>Total small vessel density will be measured by Microscan and analyzed by AVA 3.0 software</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perfused small vessel density of sublingual small vessels</measure>
    <time_frame>Once at enrollment</time_frame>
    <description>Perfused small vessel density will be measured by Microscan and analyzed by AVA 3.0 software</description>
  </secondary_outcome>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Sublingual Microcirculation Status</condition>
  <arm_group>
    <arm_group_label>1_Hypertension</arm_group_label>
    <description>Patients with diagnosed hypertension, without other systemic diseases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2_Diabetes mellitus</arm_group_label>
    <description>Patients with diagnosed diabetes mellitus, without other systemic diseases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3_Hypertension and diabetes mellitus</arm_group_label>
    <description>Patients with both diagnosed hypertension and diabetes mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4_end stage renal disease with hemodialysis</arm_group_label>
    <description>Patients with end stage renal disease with hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5_Peripheral arterial occlusive disease</arm_group_label>
    <description>Patients with disgnosed peripheral arterial occlusive disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6_Coronary artery disease</arm_group_label>
    <description>Patients with diagnosed coronary artery disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7_liver cirrhosis</arm_group_label>
    <description>Patients with diagnosed liver cirrhosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8_Anemia</arm_group_label>
    <description>Patients with diagnosed anemia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>1_Hypertension</arm_group_label>
    <arm_group_label>2_Diabetes mellitus</arm_group_label>
    <arm_group_label>3_Hypertension and diabetes mellitus</arm_group_label>
    <arm_group_label>4_end stage renal disease with hemodialysis</arm_group_label>
    <arm_group_label>5_Peripheral arterial occlusive disease</arm_group_label>
    <arm_group_label>6_Coronary artery disease</arm_group_label>
    <arm_group_label>7_liver cirrhosis</arm_group_label>
    <arm_group_label>8_Anemia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diagnosed hypertension, diabetes mellitus, both hypertension and diabetes&#xD;
        mellitus, end stage renal disease with hemodialysis, peripheral arterial occlusive disease,&#xD;
        coronary artery disease, liver cirrhosis, or anemia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged from 20 to 79 years old&#xD;
&#xD;
          -  BMI ranged from 18.5 to 27 kg/m2&#xD;
&#xD;
          -  Presence of one of the condition&#xD;
&#xD;
               1. Diagnosed hypertenison &gt; 6 months, without other systemic diseases&#xD;
&#xD;
               2. Diagnosed diabetes mellitus &gt; 6 monthes, without other systemic diseases&#xD;
&#xD;
               3. Diagnosed with both hypertension and diabetes mellitus &gt; 6 months, without other&#xD;
                  systemic diseases&#xD;
&#xD;
               4. Diagnosed with end stage renal disease and recevied renal replacement therapy &gt; 6&#xD;
                  months&#xD;
&#xD;
               5. Diagnosed with peripheral arterial occlusive diseases &gt; 6 months&#xD;
&#xD;
               6. Diagnosed with coronary artery disease &gt; 6 months&#xD;
&#xD;
               7. Diagnosed with liver cirrhosis &gt; 6 months&#xD;
&#xD;
               8. Diagnosed with anemia &gt; 6 months, hemoglobin level &lt; 10 g/dL&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with sepsis, major tauma, or admission to ICU within one month&#xD;
&#xD;
          -  Body temperature higher than 37.5 ℃ or lower than 35.5 ℃&#xD;
&#xD;
          -  Any on of the following condition&#xD;
&#xD;
               1. Asthma&#xD;
&#xD;
               2. Chronic obstructive pulmonary disease&#xD;
&#xD;
               3. Endocrine diseases&#xD;
&#xD;
               4. Hematological disorders&#xD;
&#xD;
               5. Uncured cancer&#xD;
&#xD;
               6. Chronic uncured infection&#xD;
&#xD;
               7. Other major disease with limited daily activity&#xD;
&#xD;
          -  Non-native speakers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Chang Yeh, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital, Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu-Chang Yeh, M.D., Ph.D</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>62158</phone_ext>
    <email>tonyyeh@ntuh.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital, anesthesiology department</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Chang Yeh, M.D, Ph.D.</last_name>
      <phone>886-2-23123456</phone>
      <email>tonyyeh@ntuh.gov.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>August 3, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2015</study_first_posted>
  <last_update_submitted>October 17, 2016</last_update_submitted>
  <last_update_submitted_qc>October 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

